Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
暂无分享,去创建一个
[1] D. Greenblatt,et al. Drug therapy. Clinical Pharmacokinetics (first of two parts). , 1975 .
[2] W. Banks,et al. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier , 1989, Brain Research Bulletin.
[3] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] G. Soma,et al. Biological activities of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived from cytotoxic factors produced by THP-1 cells. , 1988, Journal of Biological Response Modifiers.
[5] W. Banks,et al. Blood to brain transport of interleukin links the immune and central nervous systems. , 1991, Life sciences.
[6] H. Besedovsky,et al. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis , 1991, The Journal of Steroid Biochemistry and Molecular Biology.
[7] D. Ben-Nathan,et al. Sodium dodecylsulphate induces a breach in the blood-brain barrier and enables a West Nile virus variant to penetrate into mouse brain , 1989, Brain Research.
[8] R. L. Baldwin,et al. Formation of ion-permeable channels by tumor necrosis factor-alpha. , 1992, Science.
[9] R. Daynes,et al. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. , 1988, Journal of immunology.
[10] T. Marunouchi,et al. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture , 1989, Brain Research.
[11] N. Rothwell,et al. Interleukin-6 is a centrally acting endogenous pyrogen in the rat. , 1991, Canadian journal of physiology and pharmacology.
[12] H. Ikegami,et al. Effect of TNF-alpha on prolactin secretion from rat anterior pituitary and dopamine release from the hypothalamus: comparison with the effect of interleukin-1 beta. , 1991, Endocrinologia japonica.
[13] W. Banks,et al. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. , 1991, The Journal of pharmacology and experimental therapeutics.
[14] T. Kral,et al. The immune-hypothalamic-pituitary-adrenal axis. , 1989, Endocrine reviews.
[15] F. P. Nestel,et al. Expression of tumor necrosis factor alpha in the developing nervous system. , 1991, The International journal of neuroscience.
[16] P. Ricciardi-Castagnoli,et al. Monokine production by microglial cell clones , 1989, European journal of immunology.
[17] G. Nilaver,et al. Immunoneurology: a serum protein afferent limb to the CNS. , 1990, Advances in experimental medicine and biology.
[18] G. Pasternak,et al. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat. , 1989, Cancer research.
[19] W. Banks,et al. Inhibition of the brain to blood transport system for enkephalins and Tyr-MIF-1 in mice addicted or genetically predisposed to drinking ethanol. , 1989, Alcohol.
[20] R. Merchant,et al. Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion. , 1987, Cancer research.
[21] F. Sweep,et al. Activation of the hypothalamus-pituitary-adrenal axis by cytokines. , 1991, Acta endocrinologica.
[22] W. Fiers,et al. Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[23] T. Fahey,et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. , 1990, The Journal of clinical investigation.
[24] W. Banks,et al. The interleukins-1α, -1β, and -2 do not acutely disrupt the murine blood - brain barrier , 1992 .
[25] T. Watanabe,et al. Characteristics of fever and acute-phase response induced in rabbits by IL-1 and TNF. , 1989, The American journal of physiology.
[26] V. Diehl,et al. Phase I study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor. , 1988, Journal of biological response modifiers.
[27] W. Pardridge,et al. Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins , 1990, Journal of neurochemistry.
[28] C. Ábrahám,et al. Recombinant human tumor necrosis factor α constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets , 1992, Neuroscience Letters.
[29] W. Banks,et al. Aluminum-Induced neurotoxicity: Alterations in membrane function at the blood-brain barrier , 1989, Neuroscience & Biobehavioral Reviews.
[30] P. Triozzi,et al. Central Nervous System Toxicity of Biological Response Modifiers , 1990, Annals of the New York Academy of Sciences.
[31] J. Connor,et al. Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier , 1987, Journal of neuroscience research.
[32] C. Plata-salamán,et al. Tumor necrosis factor and interleukin-1β: suppression of food intake by direct action in the central nervous system , 1988, Brain Research.
[33] C. Sweep,et al. Cytokines and the hypothalamic-pituitary-adrenal axis , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[34] G. Pasternak,et al. Identification and characterization of receptors for tumor necrosis factor-α in the brain , 1991 .
[35] J. M. Mullin,et al. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. , 1990, Cancer research.
[36] A. R. Sherman,et al. Iron deficiency and interleukin 1 production by rat leukocytes. , 1987, The American journal of clinical nutrition.
[37] D. Scarborough. Cytokine Modulation of Pituitary Hormone Secretion a , 1990, Annals of the New York Academy of Sciences.
[38] W. Banks,et al. Chapter 21: Bidirectional passage of peptides across the blood-brain barrier , 1992 .
[39] Ronald G. Blasberg,et al. Transport of α-Aminoisobutyric Acid across Brain Capillary and Cellular Membranes , 1983 .
[40] P. Peterson,et al. Tumor Necrosis Factor-α is a Potent ACTH Secretagogue: Comparison to Interleukin-1β , 1989 .
[41] B. Storer,et al. Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. , 1991, Cancer research.
[42] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[43] E. O. Johnson,et al. Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. , 1990, Endocrinology.
[44] Y. Shimada,et al. Tumor necrosis factor reduces lifespan of human endothelial cells in vitro , 1990, Mechanisms of Ageing and Development.